Yang S, Huang H, Zhou K, Zhao X, et al. Acalabrutinib in Chinese patients with relapsed/refractory chronic lymphocytic leukemia: Primary analysis from an open-label, multicenter phase 1/2 trial. Ann Hematol 2024 Sep 14. doi: 10.1007/s00277-024-05978.
PMID: 39271521